A new method to detect RNA from bloodborne viruses like HIV and hepatitis C
Official title: An Isothermal Method to Amplify RNA from Bloodborne Viruses
Funded at Lynntech, INC. · NIH-10760602 · Data updated 2026-11-12
This study is working on a new test that makes it easier to find HIV and hepatitis C in blood samples, which could help people get more accurate results, especially in places where resources are limited.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lynntech, INC. NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $290,196 |
| NIH project number | 1R43AI170123-01A1 |
| Project ID | NIH-10760602 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for or living with HIV-1 or hepatitis C, as well as those requiring viral RNA testing.
✕Less likely to help
Patients who are not at risk for bloodborne viral infections or those who have already been diagnosed and are receiving treatment may not benefit from this research.
What this research studies
This research focuses on developing a diagnostic assay that can amplify and detect RNA from bloodborne viruses, particularly HIV-1 and hepatitis C. The approach utilizes a unique isothermal amplification process that enriches viral RNA, making it easier to identify these viruses in blood samples. By improving the accuracy of detection and reducing false positives and negatives, this method aims to enhance testing capabilities, especially in resource-limited settings. The technology could also be adapted for other viral pathogens, broadening its applicability.
Why it matters
Potential benefit: If successful, this research could provide a more accessible and accurate method for diagnosing bloodborne viral infections, improving patient outcomes.
How similar studies have gone: Other research has shown promise in developing similar RNA amplification techniques, indicating potential for success in this novel approach.
Where this research is happening
-
Lynntech, INC.
College Station, United States Active
Researchers
- Principal investigator: Gorzelnik, Karl — Lynntech, INC.
- Study coordinator: Gorzelnik, Karl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.